New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 6, 2012
16:09 EDTNVAXNovavax' Phase I RSV vaccine data published in Vaccine
Novavax today announced that the journal Vaccine has published the company's data from its 2011 Phase I clinical trial of its respiratory syncytial virus, RSV, fusion, F,recombinant nanoparticle vaccine candidate. The paper was authored by a team of researchers and clinicians at Novavax and Dr. Pedro Piedra of Baylor College of Medicine. Findings from the trial were announced in October 2011 and presented in September by Novavax at the Respiratory Virus Symposium,RSV 2012, meeting in Santa Fe, New Mexico.
News For NVAX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 27, 2015
09:24 EDTNVAXOn The Fly: Pre-market Movers
Subscribe for More Information
February 26, 2015
18:43 EDTNVAXOn The Fly: After Hours Movers
Subscribe for More Information
16:47 EDTNVAXNovavax reports Q4 EPS (13c), consensus (8c)
Reports Q4 revenue $6.72M, consensus $9.6M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use